Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berend Jan Bosch

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Science Immunology|April 26, 2022
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concernWenjuan Du, Daniel L Hurdiss, Dubravka Drabek, et al.
Nature Communications|March 15, 2024
Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate modelsFranziska K Kaiser, Mariana Gonzalez Hernandez, Nadine Krüger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2020
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19Erik H Vogelzang, Floris C Loeff, Ninotska I L Derksen, et al.
Nature|March 27, 2025
A coronavirus assembly inhibitor that targets the viral membrane proteinManon Laporte, Dirk Jochmans, Dorothée Bardiot, et al.
Nature Biotechnology|July 21, 2022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variantsSylvia Rothenberger, Daniel L Hurdiss, Marcel Walser, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Science Immunology|April 26, 2022
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concernWenjuan Du, Daniel L Hurdiss, Dubravka Drabek, et al.
Nature Communications|March 15, 2024
Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate modelsFranziska K Kaiser, Mariana Gonzalez Hernandez, Nadine Krüger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2020
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19Erik H Vogelzang, Floris C Loeff, Ninotska I L Derksen, et al.
Nature|March 27, 2025
A coronavirus assembly inhibitor that targets the viral membrane proteinManon Laporte, Dirk Jochmans, Dorothée Bardiot, et al.
Nature Biotechnology|July 21, 2022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variantsSylvia Rothenberger, Daniel L Hurdiss, Marcel Walser, et al.
Pageof 12